Biodesix obtains medicare coverage for the nodify cdt® lung nodule test

Boulder, colo.--(business wire)--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that wps government health administrators, the medicare administrative contractor with jurisdiction for biodesix's de soto, kansas laboratory, has provided coverage for the nodify cdt® lung nodule test. the nodify cdt test is a part of the biodesix's blood-based nodify lung® nodule risk assessment testing strategy consisting of two tests to a
BDSX Ratings Summary
BDSX Quant Ranking